Literature DB >> 18348474

Ethical obligations of physicians participating in public health quarantine and isolation measures.

Nathan A Bostick1, Mark A Levine, Robert M Sade.   

Abstract

In dealing with outbreaks of communicable diseases, the medical profession should work with public health authorities to promote the use of interventions that achieve desired public health outcomes with minimal infringement upon individual liberties. This article endeavors to help physicians manage their dual responsibilities to their patients and to their communities when participating in appropriate quarantine and isolation measures. In implementing such measures, individual physicians should take necessary actions to promote patients' well-being. In addition, the medical profession and individual physicians share responsibility for taking appropriate precautionary measures to protect the health of individuals caring for patients with communicable diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18348474      PMCID: PMC2099320          DOI: 10.1177/003335490812300102

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  10 in total

1.  An ethics framework for public health.

Authors:  N E Kass
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

Review 2.  Principles for the justification of public health intervention.

Authors:  R E G Upshur
Journal:  Can J Public Health       Date:  2002 Mar-Apr

3.  Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats.

Authors:  Lawrence O Gostin; Ronald Bayer; Amy L Fairchild
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

Review 4.  Ethics and SARS: lessons from Toronto.

Authors:  Peter A Singer; Solomon R Benatar; Mark Bernstein; Abdallah S Daar; Bernard M Dickens; Susan K MacRae; Ross E G Upshur; Linda Wright; Randi Zlotnik Shaul
Journal:  BMJ       Date:  2003-12-06

5.  Public health ethics: mapping the terrain.

Authors:  James F Childress; Ruth R Faden; Ruth D Gaare; Lawrence O Gostin; Jeffrey Kahn; Richard J Bonnie; Nancy E Kass; Anna C Mastroianni; Jonathan D Moreno; Phillip Nieburg
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

Review 6.  Ethical challenges in preparing for bioterrorism: barriers within the health care system.

Authors:  Matthew K Wynia; Lawrence O Gostin
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

7.  The law and the public's health: a study of infectious disease law in the United States.

Authors:  L O Gostin; S Burris; Z Lazzarini
Journal:  Columbia Law Rev       Date:  1999-01

8.  Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences.

Authors:  J Barbera; A Macintyre; L Gostin; T Inglesby; T O'Toole; C DeAtley; K Tonat; M Layton
Journal:  JAMA       Date:  2001-12-05       Impact factor: 56.272

Review 9.  Ethical considerations in the allocation of organs and other scarce medical resources among patients. Council on Ethical and Judicial Affairs, American Medical Association.

Authors: 
Journal:  Arch Intern Med       Date:  1995-01-09

10.  Emerging infectious diseases and the law.

Authors:  E P Richards
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

  10 in total
  2 in total

1.  The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts.

Authors:  Sarathi Kalra; Dhanashree Kelkar; Sagar C Galwankar; Thomas J Papadimos; Stanislaw P Stawicki; Bonnie Arquilla; Brian A Hoey; Richard P Sharpe; Donna Sabol; Jeffrey A Jahre
Journal:  J Glob Infect Dis       Date:  2014-10

2.  Attitudes of the Public to Receiving Medical Care during Emergencies through Remote Physician-Patient Communications.

Authors:  Matilda Hamlin; Steinn Steingrimsson; Itzhak Cohen; Victor Bero; Avishay Bar-Tl; Bruria Adini
Journal:  Int J Environ Res Public Health       Date:  2020-07-20       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.